Is A CURE ON the WAY? – THE BAD MEDICINE OF GENERICS, CITIZEN PETITIONS, AND NOERR-PENNINGTON IMMUNITY

Show simple item record

dc.contributor.author Lee, Stacey
dc.date.accessioned 2010-03-15T19:37:18Z
dc.date.available 2010-03-15T19:37:18Z
dc.date.issued 2010-03
dc.identifier.uri http://jhir.library.jhu.edu/handle/1774.2/34009
dc.description.abstract Over the next five years, approximately 110 drugs, including blockbuster products such as Sanofi-Aventis’ allergy medicine Flomax, GlaxoSmithKline’s herpes medication Valtrex, and Pfizer’s cholesterol medication Lipitor will lose their patent protection. In 2009 alone, brand-name drugs coming off patent were valued at more than 10.8 billion dollars. As market exclusivity for these drugs ends, the doors for generic production will open. Generic drugs generally enter the market priced 20 to 80 percent lower than their branded counterparts, and generics can capture 44 to 80 percent of brand-name drug sales within a year after release. This price competition from generic drugs threatens the profits of brand-name manufacturers and reduces their returns on innovative activity. As a result, some brand-name drug manufacturers have resorted to aggressive tactics to blunt the impact of competition. en
dc.description.provenance Submitted by Rashawna Sydnor (rsydnor@jhu.edu) on 2010-03-15T19:37:18Z No. of bitstreams: 1 SBLee Generics Noerr-Pennington Sham.pdf: 380713 bytes, checksum: 716d3962725153790ca9353abb61d9ec (MD5) en
dc.description.provenance Made available in DSpace on 2010-03-15T19:37:18Z (GMT). No. of bitstreams: 1 SBLee Generics Noerr-Pennington Sham.pdf: 380713 bytes, checksum: 716d3962725153790ca9353abb61d9ec (MD5) Previous issue date: 2010-03 en
dc.language.iso en_US en
dc.relation.ispartofseries The Johns Hopkins Carey Business School Working Paper Series;2010-03-001
dc.subject K2 en
dc.subject Citizen Petitions en
dc.subject Sham en
dc.subject Noerr-Pennington en
dc.subject Generics en
dc.title Is A CURE ON the WAY? – THE BAD MEDICINE OF GENERICS, CITIZEN PETITIONS, AND NOERR-PENNINGTON IMMUNITY en
dc.type Working Paper en

Files in this item

Files Size Format Download
SBLee Generics Noerr-Pennington Sham.pdf 380.7Kb application/pdf Download

This item appears in the following Collection(s)

Show simple item record